Form 8-K - Current report:
SEC Accession No. 0001185185-24-000916
Filing Date
2024-09-24
Accepted
2024-09-24 15:49:44
Documents
18
Period of Report
2024-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K novaccess20240923_8k.htm   iXBRL 8-K 29651
2 EXHIBIT 10.1 ex_726717.htm EX-10.1 160395
3 EXHIBIT 10.2 ex_726718.htm EX-10.2 148266
4 EXHIBIT 10.3 ex_726719.htm EX-10.3 21856
5 EXHIBIT 10.4 ex_726720.htm EX-10.4 84630
6 EXHIBIT 10.5 ex_726721.htm EX-10.5 104578
  Complete submission text file 0001185185-24-000916.txt   795880

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240918.xsd EX-101.SCH 3038
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240918_lab.xml EX-101.LAB 19178
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240918_pre.xml EX-101.PRE 10592
20 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240923_8k_htm.xml XML 2649
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

EIN.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-29621 | Film No.: 241320094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)